Denise A. Yardley

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Denise A. Yardley
Mar 4, 2025, 12:06 | Blog
Nicholas Hornstein: Results for CRC liver metastasis from the COLLISION trial
Nicholas Hornstein, Hematologist and Oncologist with Northwell Health, shared an article Susan van der Lei…
Mar 4, 2025, 11:14 | Blog
Breast Cancer Research Digest by Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: "Check out the Breast Cancer Research…
Jan 31, 2025, 07:23 | Blog
Giuseppe Curigliano: Neoadjuvant nivolumab and chemotherapy in early estrogen receptor-positive breast cancer
Giuseppe Curigliano, ESMO President-Elect and Open Editor in Chief, shared on X: "Adding nivolumab to…
Jan 28, 2025, 15:01 | Insight
Breast Cancer Research Digest by Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: "Check out the Breast Cancer Research Digest…
Jul 29, 2024, 11:19 | Insight
Rasha Aboelhassan: We can give TDM1 in stage I HER2 positive breast cancer
Rasha Aboelhassan shared a post on LinkedIn about a recent paper by Paolo Tarantino et al., commenting:…
Jul 20, 2024, 11:01 | Insight
Paolo Tarantino: Thanks to ESMO for featuring our 5-year analysis of the ATEMPT randomized phase 3 trial
Paolo Tarantino shared a post on LinkedIn about a paper titled "Adjuvant Trastuzumab Emtansine Versus…
Jul 5, 2024, 06:54 | Blog
Paolo Tarantino: Nearly 1000 downloads in less than a week for our ATEMPT 5-year publication
Paolo Tarantino, posted on X: "Nearly 1000 downloads in less than a week for our…
Jul 1, 2024, 15:23 | Insight
Paolo Tarantino: Final analysis of the ATEMPT phase 2 trial
Paolo Tarantino shared a post on X: “Can ADCs help prevent recurrence from breast cancer…
All: 8 Posts: 1 - 100
Special Coverage